Participation in lung screening as a trigger for smoking cessation: early follow-up data from LUCIA
Abstract
Background: Lung cancer is the leading cause of cancer-related deaths globally, with tobacco use as the primary risk factor. Lung cancer screening represents a potential point of care intervention to promote smoking cessation. This study evaluates the impact of participating in the LUCIA lung-screening program on smoking cessation rates and assesses whether Low-Dose CT (LDCT) findings influence the decision to quit.
Methods: We analyzed smoking habits within the LUCIA prospective cohort in the Basque Country (n = 1,486; age 40-80). All participants underwent baseline LDCT. Smoking status was assessed at baseline, 6 months, and 12 months. We compared LDCT findings (emphysema, interstitial features, pleural abnormalities and Lung-RADS categories) between those who achieved cessation and those who continued smoking using Chi-square tests.
Results: The cohort (59% female, median age 54) consisted of 47.4% ex-smokers, 25.9% never-smokers, and 26.6% (n = 396) smokers. Among baseline smokers, the cessation rate was 9.1% (n = 36) at 6 months, increasing to 15.2% (n = 60) at 12 months (p < 0.001). At 12 months, quitters (n = 60) and persistent smokers (n = 260) showed similar distributions of emphysema (33.3% vs 23.5%), interstitial features (6.7% vs 10.8%), and pleural abnormalities (6.7% vs 6.2%). Lung-RADS 1-2 nodules were present in 38.3% of quitters and 36.5% of persistent smokers. No significant association was found between the presence of at least one CT abnormality and smoking cessation at 12 months (58.3% of quitters had findings vs 55% of persistent smokers; p = 0.639).
Conclusions: The study demonstrates a significant smoking cessation rate at 1 year. However, the absence of a correlation between LDCT abnormalities and quitting success suggests that cessation was driven by the program’s participation and counseling rather than the specific radiologic findings. Participation in screening programs, regardless of individual results, serves as a key determinant for smoking cessation
Key messages: • Participation in a lung cancer screening program led to a 15.2% smoking cessation rate at 12 months, independent of LDCT findings.
• The screening process itself, rather than the presence of subclinical lung damage, acts as the primary driver for tobacco cessation.
Related
- Family based screening and smoking cessation for COPD detection: Hybrid cross-sectional and single-arm, multicenter intervention study.
- Association between duration of smoking cessation and depressive symptoms among community-dwelling older adults: a cross-sectional study
- Lung Function and Respiratory Symptoms as Factors Associated with Smoking Cessation Status in a Population-Based Study
- A Polygenic Score for Smoking Persistence Captures Differences in Cessation Age
- Actívatexto: Advancing Smoking Cessation and Physical Activity among Latino Adults. Study Protocol for a Randomized Clinical Trial
BibTeX
@article{idoyagauribarrena2026participation,
title = {{Participation in lung screening as a trigger for smoking cessation: early follow-up data from LUCIA}},
author = {J E Idoyaga-Uribarrena and J Orcajo-Lago and L García-Echeberria and E Pérez-Guzmán and M Barasoain-Hernández and V Gómez-Sánchez and S De Benito-Sobrado and I Iturbe-Susilla and M Egurrola-Izquierdo and J Cacicedo Fernández-Bobadilla},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1058},
url = {https://doi.org/10.1093/eurpub/ckag169.1058},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Participation in lung screening as a trigger for smoking cessation: early follow-up data from LUCIA
AU - J E Idoyaga-Uribarrena
AU - J Orcajo-Lago
AU - L García-Echeberria
AU - E Pérez-Guzmán
AU - M Barasoain-Hernández
AU - V Gómez-Sánchez
AU - S De Benito-Sobrado
AU - I Iturbe-Susilla
AU - M Egurrola-Izquierdo
AU - J Cacicedo Fernández-Bobadilla
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1058
UR - https://doi.org/10.1093/eurpub/ckag169.1058
AB - Background: Lung cancer is the leading cause of cancer-related deaths globally, with tobacco use as the primary risk factor. Lung cancer screening represents a potential point of care intervention to promote smoking cessation. This study evaluates the impact of participating in the LUCIA lung-screening program on smoking cessation rates and assesses whether Low-Dose CT (LDCT) findings influence the decision to quit. Methods: We analyzed smoking habits within the LUCIA prospective cohort in the Basque Country (n = 1,486; age 40-80). All participants underwent baseline LDCT. Smoking status was assessed at baseline, 6 months, and 12 months. We compared LDCT findings (emphysema, interstitial features, pleural abnormalities and Lung-RADS categories) between those who achieved cessation and those who continued smoking using Chi-square tests. Results: The cohort (59% female, median age 54) consisted of 47.4% ex-smokers, 25.9% never-smokers, and 26.6% (n = 396) smokers. Among baseline smokers, the cessation rate was 9.1% (n = 36) at 6 months, increasing to 15.2% (n = 60) at 12 months (p < 0.001). At 12 months, quitters (n = 60) and persistent smokers (n = 260) showed similar distributions of emphysema (33.3% vs 23.5%), interstitial features (6.7% vs 10.8%), and pleural abnormalities (6.7% vs 6.2%). Lung-RADS 1-2 nodules were present in 38.3% of quitters and 36.5% of persistent smokers. No significant association was found between the presence of at least one CT abnormality and smoking cessation at 12 months (58.3% of quitters had findings vs 55% of persistent smokers; p = 0.639). Conclusions: The study demonstrates a significant smoking cessation rate at 1 year. However, the absence of a correlation between LDCT abnormalities and quitting success suggests that cessation was driven by the program’s participation and counseling rather than the specific radiologic findings. Participation in screening programs, regardless of individual results, serves as a key determinant for smoking cessation Key messages: • Participation in a lung cancer screening program led to a 15.2% smoking cessation rate at 12 months, independent of LDCT findings. • The screening process itself, rather than the presence of subclinical lung damage, acts as the primary driver for tobacco cessation.
SN - 1101-1262
SN - 1464-360X
ER -